Last reviewed · How we verify

NCT05474014

Superior Trunk Block Applied for Upper Arm Surgery

Completed NA Last updated 25 January 2024
What this trial tests

NA trial testing superior trunk block in Post Operative Pain in 60 participants. Completed in 1 December 2023.

Timeline
20 July 2022
Primary endpoint
1 November 2023
1 December 2023

Quick facts

Lead sponsorBursa Yuksek Ihtisas Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date20 July 2022
Primary completion1 November 2023
Estimated completion1 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nerve blocks applied with ultrasonography are currently used for many post-operative pain and operations. Providing adequate area analgesia is the primary goal of clinicians, as early mobilization is suggested after shoulder and arm surgery. In this study aimed to investigate the effect of superior trunk block application on postoperative analgesic and motor functions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of superior trunk block

Trials testing the same drug.

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Other Bursa Yuksek Ihtisas Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing